Immunocore Holdings plc (IMCR)

Immunocore Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	476.85	455.73	442.63	402.47	322.11	177.1
Short-Term Investments	360.19	364.65	-	-	-	-
Cash & Short-Term Investments	837.03	820.38	442.63	402.47	322.11	177.1
Cash Growth	0.51%	85.34%	9.98%	24.95%	81.88%	80.79%
Accounts Receivable	63.09	63.01	52.09	33.58	8.19	2.8
Other Receivables	-	20.09	9.34	23.5	15.03	20.01
Receivables	63.09	83.1	61.44	57.08	23.22	22.81
Inventory	6.8	5.45	4.5	0.69	-	-
Prepaid Expenses	41.7	13.05	10.55	10.11	10.41	8.88
Other Current Assets	-	7.9	9.71	3.62	-	-
Total Current Assets	948.63	929.86	528.82	473.98	355.75	208.8
Property, Plant & Equipment	47.9	47.74	42.74	38.78	42.7	50.31
Long-Term Accounts Receivable	-	-	-	-	-	1.06
Long-Term Deferred Tax Assets	14.36	14.79	10.97	5.12	3.49	3.04
Other Long-Term Assets	17.13	17.12	14.47	8.89	6.68	6.02
Total Assets	1,028	1,010	597	526.76	408.62	269.23
Accounts Payable	29.11	25.1	17.8	14.45	10.15	7.9
Accrued Expenses	118.34	180.77	115.48	73.09	37.11	26.38
Current Portion of Leases	1.72	1.55	1.39	1.88	1.7	2.79
Current Income Taxes Payable	-	-	-	1.12	0.72	0.85
Current Unearned Revenue	-	-	-	7.76	33.11	37.02
Other Current Liabilities	-	4.76	4.36	2.54	0.05	0.15
Total Current Liabilities	149.16	212.18	139.02	100.84	82.84	75.09
Long-Term Debt	391.53	391.01	48.01	47.81	50.41	50.04
Long-Term Leases	40.75	40.16	35.61	31.76	34.33	34.39
Long-Term Unearned Revenue	5.61	5.43	5.52	5.24	8.68	33.95
Other Long-Term Liabilities	62.48	-	-	2.22	0.08	0.19
Total Liabilities	649.53	648.79	228.16	187.86	176.33	193.67
Common Stock	0.14	0.14	0.13	0.13	0.12	0.09
Additional Paid-In Capital	1,202	1,190	1,150	1,083	287.38	-
Retained Earnings	-790.74	-795.76	-744.67	-689.39	-651.83	-477.68
Comprehensive Income & Other	-33.09	-33.76	-36.26	-54.67	596.62	553.15
Shareholders' Equity	378.48	360.72	368.84	338.9	232.28	75.56
Total Liabilities & Equity	1,028	1,010	597	526.76	408.62	269.23
Total Debt	434	432.72	85.01	81.45	86.44	87.22
Net Cash (Debt)	403.04	387.65	357.62	321.02	235.67	89.88
Net Cash Growth	11.94%	8.40%	11.40%	36.22%	162.22%	366.11%
Net Cash Per Share	8.05	7.75	7.31	7.02	5.55	3.39
Filing Date Shares Outstanding	50.23	50.07	49.82	48.12	43.86	43.79
Total Common Shares Outstanding	50.18	50.06	49.73	48.09	43.86	2.68
Working Capital	799.46	717.68	389.8	373.14	272.91	133.71
Book Value Per Share	7.54	7.20	7.42	7.05	5.30	28.20
Tangible Book Value	378.48	360.72	368.84	338.9	232.28	75.56
Tangible Book Value Per Share	7.54	7.20	7.42	7.05	5.30	28.20
Machinery	-	43.92	41.46	33.98	36.29	35.47
Construction In Progress	-	0.48	0.05	0.43	0.02	0.16
Leasehold Improvements	-	21.02	20.02	19.1	21.18	21.59

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q